Literature DB >> 21354173

Unanticipated signaling events associated with cardiac adenylyl cyclase gene transfer.

Mei Hua Gao1, H Kirk Hammond.   

Abstract

The published papers on the effects of increased cardiac expression of adenylyl cyclase type 6 (AC6) are reviewed. These include the effects of AC on normal and failing left ventricle in several pathophysiological models in mice and pigs. In addition, the effects of increased expression of AC6 in cultured neonatal and adult rat cardiac myocytes are discussed in the context of attempting to establish mechanisms for the unanticipated beneficial effects of AC6 on the failing heart. This article is part of a Special Section entitled "Special Section: Cardiovascular Gene Therapy".
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21354173      PMCID: PMC3095111          DOI: 10.1016/j.yjmcc.2011.02.009

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  97 in total

1.  Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

Authors:  S Engelhardt; L Hein; F Wiesmann; M J Lohse
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

2.  Galphaq-coupled receptor signaling enhances adenylate cyclase type 6 activation.

Authors:  Michael A Beazely; Val J Watts
Journal:  Biochem Pharmacol       Date:  2005-07-01       Impact factor: 5.858

3.  Two-metal-Ion catalysis in adenylyl cyclase.

Authors:  J J Tesmer; R K Sunahara; R A Johnson; G Gosselin; A G Gilman; S R Sprang
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

4.  Nitroprusside increases gene transfer associated with intracoronary delivery of adenovirus.

Authors:  David M Roth; N Chin Lai; Mei Hua Gao; Suzanne Fine; M Dan McKirnan; David A Roth; H Kirk Hammond
Journal:  Hum Gene Ther       Date:  2004-10       Impact factor: 5.695

5.  Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy.

Authors:  D M Roth; M H Gao; N C Lai; J Drumm; N Dalton; J Y Zhou; J Zhu; D Entrikin; H K Hammond
Journal:  Circulation       Date:  1999-06-22       Impact factor: 29.690

6.  Transgenic replacement of type V adenylyl cyclase identifies a critical mechanism of beta-adrenergic receptor dysfunction in the G alpha q overexpressing mouse.

Authors:  N M Tepe; S B Liggett
Journal:  FEBS Lett       Date:  1999-09-17       Impact factor: 4.124

7.  Histidine residues 912 and 913 in protein associated with Myc are necessary for the inhibition of adenylyl cyclase activity.

Authors:  Xianlong Gao; Tarun B Patel
Journal:  Mol Pharmacol       Date:  2004-10-06       Impact factor: 4.436

8.  Protein kinase C and epidermal growth factor stimulation of Raf1 potentiates adenylyl cyclase type 6 activation in intact cells.

Authors:  Michael A Beazely; Jamie K Alan; Val J Watts
Journal:  Mol Pharmacol       Date:  2004-10-06       Impact factor: 4.436

9.  Modeling of Galpha(s) and Galpha(i) regulation of human type V and VI adenylyl cyclase.

Authors:  Misty Chen-Goodspeed; Abolanle N Lukan; Carmen W Dessauer
Journal:  J Biol Chem       Date:  2004-11-15       Impact factor: 5.157

10.  The fine structure of the gall bladder epithelium of the mouse.

Authors:  E YAMADA
Journal:  J Biophys Biochem Cytol       Date:  1955-09-25
View more
  3 in total

Review 1.  Cardiovascular gene therapy for myocardial infarction.

Authors:  Maria C Scimia; Anna M Gumpert; Walter J Koch
Journal:  Expert Opin Biol Ther       Date:  2013-12-16       Impact factor: 4.388

2.  Non-raft adenylyl cyclase 2 defines a cAMP signaling compartment that selectively regulates IL-6 expression in airway smooth muscle cells: differential regulation of gene expression by AC isoforms.

Authors:  Amy S Bogard; Anna V Birg; Rennolds S Ostrom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-12-22       Impact factor: 3.000

3.  The type VI adenylyl cyclase protects cardiomyocytes from β-adrenergic stress by a PKA/STAT3-dependent pathway.

Authors:  Yu-Shuo Wu; Chien-Chang Chen; Chen-Li Chien; Hsing-Lin Lai; Si-Tse Jiang; Yong-Cyuan Chen; Lin-Ping Lai; Wei-Fan Hsiao; Wen-Pin Chen; Yijuang Chern
Journal:  J Biomed Sci       Date:  2017-09-04       Impact factor: 8.410

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.